New treatment for Multiple Sclerosis has been discovered!

     Finally, after awaited decades, a new treatment was found for the rare chronic disease of Multiple Sclerosis (M.S). A swiss drugmaker in the German company, Novartis gained approval for its pill, Gilenya, by the American regulators. The Food and Drug Adminstration supported Gilenya, which has said to treat the common form of the disease, relapsing M.S. Stated in the New York Times, Novartis claims,

Gilenya reduced the frequency of M.S. relapses and helped to slow the advance of some of he physical problems caused by the disease, and the drug had a well-studied safety and tolerability level.

I'm sure this new revelation has brought hope to many people who suffer with this unbarable disease. What's benefical about this very pill, is that the drug will slow down the physcial effects of the disease, which intially could lengthen the lifespan of those who suffer from M.S. This proves to be the first small step of many to find a cure for M.S and finally help those who are in need of it. Although it is a rare condition, primarly found in women rather than men, it causes grave liabilty for families who take care of these patients. The victim of the disease are not the only people that suffer from it. Hopefully in the near future, America will unlease a cure for this small, but life threating disease.